ABSTRACT
Infection is common among patients with acute leukemia [I]. The frequency and type of infections complicating acute myelogenous leukemia (AML) depends on the state of disease and the treatment status [2]. Two-thirds of patients with AML develop infection after remission induction chemotherapy, and one-third do so after consolidation therapy [3,4]. There is a marked reduction in the probability of infection once remission has been achieved and the bone marrow and peripheral blood have been repopulated with morphologically and functionally normal cells.
